COVID-19 in the Tibet, China, the roof of the world: a comparative analysis of high-altitude residents and newcomers.

IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES BMC Infectious Diseases Pub Date : 2024-09-02 DOI:10.1186/s12879-024-09831-x
Xiaosong Yan, Ying Shan, Qiaoxia Luo, Dongmei Liu, Yanfei Zhang, Qiangrong Zhai, Zhenxing Zhou, Weikai Wang, Ba La, Jingting Yan, Xiaoyao Zhu, Xinxin Wang, Langjie Thuen, Wei Chen, Qian Li, Jian Zeng, Gang Tian, Xiaoli Chen, Qu Ci, Qidi Zhou, Xin Jin, Tashi Pingcuo
{"title":"COVID-19 in the Tibet, China, the roof of the world: a comparative analysis of high-altitude residents and newcomers.","authors":"Xiaosong Yan, Ying Shan, Qiaoxia Luo, Dongmei Liu, Yanfei Zhang, Qiangrong Zhai, Zhenxing Zhou, Weikai Wang, Ba La, Jingting Yan, Xiaoyao Zhu, Xinxin Wang, Langjie Thuen, Wei Chen, Qian Li, Jian Zeng, Gang Tian, Xiaoli Chen, Qu Ci, Qidi Zhou, Xin Jin, Tashi Pingcuo","doi":"10.1186/s12879-024-09831-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>After a 920-day hiatus, COVID-19 resurged in the Tibet Autonomous Region of China in August 2022. This study compares the characteristics of COVID-19 between high-altitude residents and newcomers, as well as between newcomers and lowlanders.</p><p><strong>Methods: </strong>This multi-center cohort study conducted at the Third People's Hospital of Tibet Autonomous Region and Beijing University Shenzhen Hospital, included 520 high-altitude resident patients, 53 high-altitude newcomer patients, and 265 lowlander patients infected with the Omicron variant. Initially, we documented epidemiological, clinical, and treatment data across varying residency at admission. We compared the severity of COVID-19 and various laboratory indicators, including hemoglobin concentration and SpO2%, over a 14-day period from the date of the first positive nucleic acid test, as well as the differences in treatment methods and disease outcomes between highlanders and high-altitude newcomers. We also compared several characteristics of COVID-19 between high-altitude newcomers and lowlanders. Univariate analysis, multivariable logistic regression, and the generalized linear mixed model were utilized for the analysis.</p><p><strong>Results: </strong>No fatalities were observed. The study found no significant differences in COVID-19 severity or in the physiological measures of hemoglobin concentration and SpO<sub>2</sub>% between high-altitude and lowland residents. Similarly, there were no statistically significant differences in the values or trends of hemoglobin and SpO<sub>2</sub>% between high-altitude residents and newcomers throughout the 14-day observation period. However, compared to age- and sex-matched lowlander patients (1:5 ratio), high-altitude newcomers exhibited higher heart rates, respiratory rates, and average hemoglobin concentrations, along with lower platelet counts. There were no significant differences in hospital stays between the two groups.</p><p><strong>Conclusions: </strong>High-altitude residents and newcomer patients exhibit clinical similarities. However, the clinical characteristics of high-altitude newcomers and lowlander patients differ due to the impact of the high-altitude environment. These results highlight potential considerations for public health strategies in high-altitude regions such as Tibet.</p>","PeriodicalId":8981,"journal":{"name":"BMC Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11370051/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12879-024-09831-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: After a 920-day hiatus, COVID-19 resurged in the Tibet Autonomous Region of China in August 2022. This study compares the characteristics of COVID-19 between high-altitude residents and newcomers, as well as between newcomers and lowlanders.

Methods: This multi-center cohort study conducted at the Third People's Hospital of Tibet Autonomous Region and Beijing University Shenzhen Hospital, included 520 high-altitude resident patients, 53 high-altitude newcomer patients, and 265 lowlander patients infected with the Omicron variant. Initially, we documented epidemiological, clinical, and treatment data across varying residency at admission. We compared the severity of COVID-19 and various laboratory indicators, including hemoglobin concentration and SpO2%, over a 14-day period from the date of the first positive nucleic acid test, as well as the differences in treatment methods and disease outcomes between highlanders and high-altitude newcomers. We also compared several characteristics of COVID-19 between high-altitude newcomers and lowlanders. Univariate analysis, multivariable logistic regression, and the generalized linear mixed model were utilized for the analysis.

Results: No fatalities were observed. The study found no significant differences in COVID-19 severity or in the physiological measures of hemoglobin concentration and SpO2% between high-altitude and lowland residents. Similarly, there were no statistically significant differences in the values or trends of hemoglobin and SpO2% between high-altitude residents and newcomers throughout the 14-day observation period. However, compared to age- and sex-matched lowlander patients (1:5 ratio), high-altitude newcomers exhibited higher heart rates, respiratory rates, and average hemoglobin concentrations, along with lower platelet counts. There were no significant differences in hospital stays between the two groups.

Conclusions: High-altitude residents and newcomer patients exhibit clinical similarities. However, the clinical characteristics of high-altitude newcomers and lowlander patients differ due to the impact of the high-altitude environment. These results highlight potential considerations for public health strategies in high-altitude regions such as Tibet.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
世界屋脊中国西藏的 COVID-19:高海拔地区居民与新移民的对比分析。
背景:在中断了920天之后,COVID-19于2022年8月在中国西藏自治区再次出现。本研究比较了高海拔地区居民与新迁入者以及新迁入者与低地居民之间的COVID-19特征:这项多中心队列研究在西藏自治区第三人民医院和北京大学深圳医院进行,共纳入了520名高原居民患者、53名高原新移民患者和265名感染了Omicron变异体的低地居民患者。最初,我们记录了入院时不同居住地的流行病学、临床和治疗数据。我们比较了从第一次核酸检测呈阳性之日起 14 天内 COVID-19 的严重程度和各种实验室指标,包括血红蛋白浓度和 SpO2%,以及高原人和高海拔新移民在治疗方法和疾病结果上的差异。我们还比较了高海拔地区和低海拔地区新移民 COVID-19 的几个特征。分析采用了单变量分析、多变量逻辑回归和广义线性混合模型:没有发现死亡事故。研究发现,高海拔地区和低海拔地区居民的 COVID-19 严重程度以及血红蛋白浓度和 SpO2% 等生理指标均无明显差异。同样,在整个 14 天的观察期间,高海拔地区居民和新来者之间的血红蛋白和 SpO2% 值或趋势也没有明显的统计学差异。然而,与年龄和性别相匹配的低地患者(1:5 比例)相比,高海拔地区的新来者表现出更高的心率、呼吸频率和平均血红蛋白浓度,以及更低的血小板计数。两组患者的住院时间没有明显差异:结论:高海拔地区居民和新移民患者的临床表现相似。然而,由于高海拔环境的影响,高海拔新移民和低地患者的临床特征有所不同。这些结果凸显了西藏等高海拔地区公共卫生策略的潜在考虑因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Infectious Diseases
BMC Infectious Diseases 医学-传染病学
CiteScore
6.50
自引率
0.00%
发文量
860
审稿时长
3.3 months
期刊介绍: BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
期刊最新文献
Neuro-leishmaniasis with cauda equina syndrome and cranial nerve palsy: a rare manifestation of recurrent atypical visceral leishmaniasis. Antimicrobial stewardship programs in a Mexican private healthcare system: a self-assessment of core elements. Description of clinical cases and available diagnostic tools of oropharyngeal syphilis: a systematic review of the literature. Long COVID and recovery from Long COVID: quality of life impairments and subjective cognitive decline at a median of 2 years after initial infection. Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1